{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T15:31:55Z","timestamp":1773675115771,"version":"3.50.1"},"reference-count":71,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2009,5,11]],"date-time":"2009-05-11T00:00:00Z","timestamp":1242000000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neurochemistry"],"published-print":{"date-parts":[[2009,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Antipsychotics are established drugs in schizophrenia treatment which, however, are not free of side effects. Lipid rafts are critical for normal brain function. Several G protein\u2010coupled receptors, such as somatostatin (SRIF) receptors, have been shown to localize to lipid rafts. The aim of this study was to investigate whether haloperidol treatment affects the composition and functionality of lipid rafts in SH\u2010SY5Y neuroblastoma cells. Haloperidol inhibited cholesterol biosynthesis, leading to a marked reduction in cell cholesterol content and to an accumulation of sterol intermediates, particularly cholesta\u20108,14\u2010dien\u20103\u03b2\u2010ol. These changes were accompanied by a loss of flotillin\u20101 and Fyn from the lipid rafts. We next studied the functionality of the SRIF receptor. Treatment with haloperidol reduced the inhibitory effect of SRIF on adenylyl cyclase (AC) activity. On the other side, haloperidol decreased basal AC activity but increased forskolin\u2010stimulated AC activity. Addition of free cholesterol to the culture medium abrogated the effects of haloperidol on lipid raft composition and SRIF signaling whereas the AC response to forskolin remained elevated. The results show that haloperidol, by affecting cholesterol homeostasis, ultimately alters SRIF signaling and AC activity, which might have physiological consequences.<\/jats:p>","DOI":"10.1111\/j.1471-4159.2009.06159.x","type":"journal-article","created":{"date-parts":[[2009,5,11]],"date-time":"2009-05-11T05:05:55Z","timestamp":1242018355000},"page":"631-640","source":"Crossref","is-referenced-by-count":14,"title":["Effects of the antipsychotic drug haloperidol on the somastostatinergic system in SH\u2010SY5Y neuroblastoma cells"],"prefix":"10.1111","volume":"110","author":[{"given":"Jana","family":"S\u00e1nchez\u2010Wandelmer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto M.","family":"Hern\u00e1ndez\u2010Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Cano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"D\u00e1valos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gema","family":"De La Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilian","family":"Puebla\u2010Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Arilla\u2010Ferreiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A.","family":"Lasunci\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebeca","family":"Busto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,6,25]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.22.12157"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo-111-4-1376"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(99)00939-8"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(84)90417-8"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M611763200"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2008.04.036"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2006.06.002"},{"key":"e_1_2_7_9_1","first-page":"323","article-title":"Haloperidol induces the nuclear translocation of phosphatidylinositol 3\u2032\u2010kinase to disrupt Akt phosphorylation in PC12 cells","volume":"32","author":"Dai Y.","year":"2007","journal-title":"J. Psychiatry Neurosci."},{"key":"e_1_2_7_10_1","first-page":"476","article-title":"Correlations between water maze performance and cortical somatostatin mRNA and high\u2010affinity binding sites during ageing in rats","volume":"8","author":"Dournaud P.","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"e_1_2_7_11_1","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1523\/JNEUROSCI.18-03-01056.1998","article-title":"Interrelationships between somatostatin sst2A receptors and somatostatin\u2010containing axons in rat brain: evidence for regulation of cell surface receptors by endogenous somatostatin","volume":"18","author":"Dournaud P.","year":"1998","journal-title":"J. Neurosci."},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.301.1.197"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2460-05.2005"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M400407-JLR200"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-7-69"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/glia.20406"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.67.1.305"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0701196"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161206778559614"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2005.05.009"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2006.10.032"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.wnr.0000199460.24412.04"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0952-3278(92)90059-R"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(99)00610-2"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/0166-2236(95)98374-8"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.37.5.321"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(02)01654-4"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2008.02.019"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.156.6.885"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(84)90074-X"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1177\/002215549804601103"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1210\/en.2005-1426"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature04399"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(96)00119-0"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001556"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi961996m"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0005-2736(03)00235-9"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M405806200"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M306440200"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(80)90515-1"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2007.01.023"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0705947"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M313440200"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2008.11.020"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-1771"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M007454200"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1006\/frne.1999.0183"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-540-72843-6_7"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v68n1113"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/0143-4179(89)90086-3"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2005.05.005"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(88)91073-6"},{"key":"e_1_2_7_53_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi9528154"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.1139\/y77-034"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00733640"},{"key":"e_1_2_7_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(89)90889-5"},{"key":"e_1_2_7_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(95)00117-O"},{"key":"e_1_2_7_58_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.37.22434"},{"key":"e_1_2_7_59_1","first-page":"413","article-title":"Further studies on the effect of butyrophenones on cholesterol synthesis in humans","volume":"9","author":"Simpson G. M.","year":"1967","journal-title":"Curr. Ther. Res. Clin. Exp."},{"key":"e_1_2_7_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2006.08.069"},{"key":"e_1_2_7_61_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.16.9690"},{"key":"e_1_2_7_62_1","first-page":"30","article-title":"The effect of a substituted fluorobutyrophenone (haloperidol) on the metabolism of sterols in rat skin","volume":"96","author":"Summerly R.","year":"1965","journal-title":"Biochem. J."},{"key":"e_1_2_7_63_1","doi-asserted-by":"publisher","DOI":"10.1002\/syn.20041"},{"key":"e_1_2_7_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcis.2008.01.034"},{"key":"e_1_2_7_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(86)90210-8"},{"key":"e_1_2_7_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-2236(02)02215-4"},{"key":"e_1_2_7_67_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-004-0109-z"},{"key":"e_1_2_7_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2005.01.005"},{"key":"e_1_2_7_69_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9568.2000.00249.x"},{"key":"e_1_2_7_70_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj2120331"},{"key":"e_1_2_7_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2008.07.026"},{"key":"e_1_2_7_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2004.09.068"}],"container-title":["Journal of Neurochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-4159.2009.06159.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1471-4159.2009.06159.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T21:29:15Z","timestamp":1697318955000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-4159.2009.06159.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,25]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["10.1111\/j.1471-4159.2009.06159.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06159.x","archive":["Portico"],"relation":{},"ISSN":["0022-3042","1471-4159"],"issn-type":[{"value":"0022-3042","type":"print"},{"value":"1471-4159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,25]]}}}